Skip to main content
. 2022 Dec 30;11(1):84. doi: 10.3390/vaccines11010084

Table 2.

Temporal pattern of vaccine induced COVID-19 antibody in overall cohort (n = 135).

COVID-19 Antibody Time of Specimen Collection (Days)
After the First Dose 60 Days after Second Dose 150 Days after Second Dose 270 Days after Second Dose
Anti-Spike antibody 77.2 (19.4–329.4) 512 (114.5–9212) 149 (51.6–2283) 2079 (433.9–8644)
Neutralising antibody (%) 22.1 (8.5–54.2) 52.3 (7.7–92.7) 41.1 (3.8–86.4) 58.6 (17.6–85.1)

Anti-spike antibody titre is expressed as U/mL and neutralising antibody is expressed in percentage. The anti-spike antibody titre value ≥ 0.80 U/mL is considered positive. The specimens with calculated neutralisation ≥ 20% are considered positive for neutralising antibody. Data are expressed as median (inter quartile range).